Effect OF Heparin solution for prevention of pain and swelling at the site of peripheral intravenous catheter.

Not Applicable

Completed

• Conditions: Health Condition 1: O- Medical and Surgical

• Registration Number: CTRI/2017/10/010089
• Lead Sponsor: PARUL INSTITUTE OF MEDICAL SCIENCE AND RESEARCH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2018-09-15
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Planned to undergo peripheral vein cannulation that has been planned to remain in situ for at least 48 hours of indoor period

Exclusion Criteria

1.Undergoing re-cannulation due to phlebitis at earlier cannulation site 2.Unconscious or comatose patients

3.History of hypersensitivity reaction to heparin or heparin induced thrombocytopenia

4. Signs of systemic infection, bacteremia

5. Planned administration of any of the following during study period:

5.1 Anti-coagulants locally (in the cannula) or systemically.

5.2 NSAIDs locally over surrounding area

6. Participated in any clinical trial within last 30 days at the time of screening.

7. Any disorder or condition that in the opinion of investigator would prohibit study participation or affect study outcome.

Study & Design

• Study Type: Interventional
• Study Design: Not specified